FDA Approves Tremfya for Active Crohn Disease in Adults
2025-03-24
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn diseaseContinue Reading
Kennedy Orders Takedown of Fake CDC Vaccine Web Page
2025-03-24
MONDAY, March 24, 2025 (HealthDay News) — A fake web page designed to look like the U.S. Centers for Disease Control and Prevention’s (CDC) vaccine safety site has been taken down on orders from health secretary Robert F. Kennedy Jr. The site was linked to Children’s Health Defense, an anti-vaccineContinue Reading
FDA OKs Amvuttra To Treat Heart Conditions
2025-03-24
MONDAY, March 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to treat transthyretin amyloid cardiomyopathy (ATTR-CM). ATTR-CM isContinue Reading
Robert F. Kennedy Jr. Downplays Measles Vaccine as Cases Surge
2025-03-13
THURSDAY, March 13, 2025 (HealthDay News) — A growing measles outbreak has led to 222 reported cases across Texas, New Mexico and Oklahoma in 2025, with health officials urging more people to get vaccinated. During an interview with Fox News, U.S. Health and Human Services (HHS) Secretary Robert F. KennedyContinue Reading
NIH Cuts Funding for Studies on Vaccine Hesitancy and Acceptance
2025-03-11
TUESDAY, March 11, 2025 (HealthDay News) — The National Institutes of Health (NIH) is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance, according to an email obtained by The Washington Post. The message — sent Monday by Michelle Bulls, director ofContinue Reading
CDC To Study Vaccines and Autism, Despite Much Research Showing No Link
2025-03-10
MONDAY, March 10, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) is preparing to study whether vaccines are linked to autism — despite overwhelming scientific evidence showing no connection. The study request came from Trump administration officials, according to sources familiar with the plan. BothContinue Reading
-690x550.jpg)
FDA Approves TNKase for Acute Ischemic Stroke
2025-03-06
The five-second intravenous bolus offers faster, simpler administration than ActivaseContinue Reading
Florida Seeks Patient Prescription Data
2025-03-06
THURSDAY, March 6, 2025 (HealthDay News) — Florida’s insurance regulator is demanding detailed prescription data on millions of patients, raising alarms over patient privacy. In January, the Florida Office of Insurance Regulation asked pharmacy benefit managers — companies that manage prescription drug plans — to hand over highly personal dataContinue Reading
Paxlovid May Offer Little Benefit for Vaccinated Older Adults
2025-03-06
THURSDAY, March 6, 2025 (HealthDay News) — The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for vaccinated older adults after all. Research published recently in JAMA Network Open looked at data from more than 1.6 million adults ages 65 to 74 in Ontario, Canada,Continue Reading
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children
2025-03-05
Odactra is an immunotherapy for treatment of house dust mite-induced allergic rhinitisContinue Reading